Sangamo Therapeutics, Inc., Issuer and [Trustee], Trustee INDENTURE Dated as of , 20 SUBORDINATED DEBT SECURITIESIndenture • May 26th, 2017 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances) • Delaware
INDENTURE, dated as of [*], 20 , among Sangamo Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
